National Heart and Lung Institute, Imperial College London, London, UK.
Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
Cardiovasc Res. 2022 Jun 22;118(7):1758-1770. doi: 10.1093/cvr/cvab210.
Takotsubo syndrome (TTS) is an acute heart failure, typically triggered by high adrenaline during physical or emotional stress. It is distinguished from myocardial infarction (MI) by a characteristic pattern of ventricular basal hypercontractility with hypokinesis of apical segments, and in the absence of culprit coronary occlusion. We aimed to understand whether recently discovered circulating biomarkers miR-16 and miR-26a, which differentiate TTS from MI at presentation, were mechanistically involved in the pathophysiology of TTS.
miR-16 and miR-26a were co-overexpressed in rats with AAV and TTS induced with an adrenaline bolus. Untreated isolated rat cardiomyocytes were transfected with pre-/anti-miRs and functionally assessed. Ventricular basal hypercontraction and apical depression were accentuated in miR-transfected animals after induction of TTS. In vitro miR-16 and/or miR-26a overexpression in isolated apical (but not basal), cardiomyocytes produced strong depression of contraction, with loss of adrenaline sensitivity. They also enhanced the initial positive inotropic effect of adrenaline in basal cells. Decreased contractility after TTS-miRs was reproduced in non-failing human apical cardiomyocytes. Bioinformatic profiling of miR targets, followed by expression assays and functional experiments, identified reductions of CACNB1 (L-type calcium channel Cavβ subunit), RGS4 (regulator of G-protein signalling 4), and G-protein subunit Gβ (GNB1) as underlying these effects.
miR-16 and miR-26a sensitize the heart to TTS-like changes produced by adrenaline. Since these miRs have been associated with anxiety and depression, they could provide a mechanism whereby priming of the heart by previous stress causes an increased likelihood of TTS in the future.
心肌顿抑综合征(TTS)是一种急性心力衰竭,通常由身体或情绪应激时肾上腺素升高引起。它与心肌梗死(MI)不同,其特征为心室基底部收缩力增强伴心尖段运动减弱,并且不存在罪犯性冠状动脉闭塞。我们旨在了解最近发现的循环生物标志物 miR-16 和 miR-26a 是否在发病时将 TTS 与 MI 区分开来,是否在 TTS 的病理生理学中具有机制性作用。
在接受腺嘌呤核苷病毒(AAV)和肾上腺素冲击诱导 TTS 的大鼠中共同过表达 miR-16 和 miR-26a。用前体/抗 miR 转染未处理的分离大鼠心肌细胞,并进行功能评估。在 TTS 诱导后,转染 miR 的动物的心室基底部收缩增强和心尖部凹陷加重。在体外,miR-16 和/或 miR-26a 在分离的心尖细胞(而非基底部)中的过表达导致收缩明显减弱,并丧失对肾上腺素的敏感性。它们还增强了基底部细胞中肾上腺素的初始正性变力作用。在非衰竭的人心尖细胞中重现了 TTS-miRs 后的收缩力降低。通过生物信息学对 miR 靶标进行分析,随后进行表达分析和功能实验,发现 CACNB1(L 型钙通道 Cavβ亚基)、RGS4(G 蛋白信号转导调节因子 4)和 G 蛋白亚基 Gβ(GNB1)的表达减少是导致这些效应的原因。
miR-16 和 miR-26a 使心脏对肾上腺素引起的 TTS 样变化敏感。由于这些 miRs 与焦虑和抑郁有关,它们可能提供了一种机制,即先前的应激使心脏处于预备状态,从而增加了未来发生 TTS 的可能性。